“Operational Data Management within the Clinical Trials Network of the National Institute on Drug Abuse (NIDA CTN)”, in 20th Annual Conference of the Society for Clinical Data Management, Las Vegas, NV, 2014.
, “Monitoring Medication Adherence Electronically: Considerations and a Case Study”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
, “Optimizing an Existing Data Collection System for Tablet Compatibility: Considerations and a Case Study”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
, “Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.”, Nat Med, vol. 9, no. 4, pp. 416-23, 2003.
, “Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning”, Nature Medicine, vol. 9, pp. 416-423, 2003.
, “Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: BMT CTN Protocol”, Biol Blood Marrow Transplant, vol. 20, pp. 858-864, 2014.
, “Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials ne”, Biol Blood Marrow Transplant, vol. 20, no. 6, pp. 858-64, 2014.
, “Induction of human T-Cell-Mediated immune responses after primary and secondary smallpox vaccination”, J Infectious Diseases, vol. 190, pp. 1286-94, 2004.
, “Genome-wide analysis of disease progression in age-related macular degeneration.”, Hum Mol Genet, vol. 27, no. 5, pp. 929-940, 2018.
, “Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial.”, Neurology, vol. 63, no. 9, pp. 1705-7, 2004.
, “Impact of Antioxidants, Zinc, and Copper on Cognition in the Elderly: A Randomized, Controlled Trial”, Neurology, vol. 63, pp. 1705-1707, 2004.
, , “Design of the Buprenorphine Physician-Pharmacist Collaborative Care of Patients with Opioid Use Disorder. ”, in 81st Annual Scientific Meeting of the College of Problems on Drug Disorders (CPDD), , San Antonio, TX. , 2019.
, “Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool.”, Contemp Clin Trials, vol. 50, pp. 90-7, 2016.
, , “Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study.”, Contemp Clin Trials, vol. 46, pp. 30-38, 2016.
, “Testing and linkage to HIV care in China: a cluster-randomised trial.”, Lancet HIV, vol. 4, no. 12, pp. e555-e565, 2017.
, “DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.”, Drug Alcohol Depend, vol. 179, pp. 42-46, 2017.
, “Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.”, JAMA Intern Med, vol. 174, no. 5, pp. 763-71, 2014.
, “Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research G”, Ophthalmology, vol. 124, no. 4, pp. 479-487, 2017.
, “Implementation of a Medication and Supply Inventory and Resupply Process - Increasing the Efficiency of the Tracking and Distribution of Supplies in Clinical Trials”, in Society for Clinical Trials (SCT) 36th Annual Meeting (2015), Arlington, VA, 2015.
, “Clinical trials referral resource. Current clinical trials for the proteosome inhibitor PS-341”, Oncology, vol. 14, pp. 1589-15901593-94
1597, 2000.
, “Clinical trials referral resource. Clinical trials of flavopiridol.”, Oncology (Williston Park), vol. 12, no. 7, pp. 1018, 1023-4, 1998.
, “Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein.”, J Infect Dis, vol. 189, no. 7, pp. 1221-31, 2004.
, “Clinical trials referral resource. Clinical trials with the farnesyl transferase inhibitor R115777.”, Oncology (Williston Park), vol. 13, no. 11, p. 1527, 1530, 1533, 1999.
,